Host: Rabbit
Target Protein: LGALS3BP
Immunogen Range: 301-400/585
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 3959
Swiss Prot: Q08380
Source: KLH conjugated synthetic peptide derived from human LGALS3BP
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
Predicted Molecular Weight: 63
Cross Reactive Species:
Human
Mouse
Rat
For research use only. Not intended for diagnostic or therapeutic use.
- Stampolidis, P., A. Ullrich, and S. Iacobelli. "LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention." Oncogene (2013).Read more>>
Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-LGALS3BP Polyclonal Antibody, Unconjugated (bs-5729R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Lane 1: Mouse Heart tissue lysates; Lane 2: Mouse Kidney tissue lysates; Lane 3: Rat Heart tissue lysates; Lane 4: Rat Kidney tissue lysates probed with LGALS3BP Polyclonal Antibody, Unconjugated (bs-5729R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Mouse Heart Lysates; Lane 2: Mouse Kidney Lysates; Lane 3: Rat Heart Lysates; Lane 4: Rat Kidney Lysates. Probed with LGALS3BP polyclonal Antibody, unconjugated (bs-5729R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.